{
    "nct_id": "NCT04623801",
    "official_title": "Pilot Study to Evaluate the Safety and Efficacy of Percutaneous Laser Ablation of Thyroid Papillary Microcarcinoma",
    "inclusion_criteria": "* Age ≥ 18 years\n* Papillary thyroid cancer documented by\n\n  * (a) Bethesda VI cytology,\n  * (b) Bethesda III, IV, V, or VI cytology AND BRAF V600E mutation, or\n  * (c) Bethesda V cytology AND high risk ultrasonographic features documented by either the ATA high suspicion or TIRADS 5 nodule characteristics\n\nTo ensure the majority of cases will be eligible based on criteria (a) or (b), we will enroll ≤ 2 patients based on criteria (c).\n\n* Maximum diameter ≤ 13 mm\n* Declined active surveillance\n* The thyroid lesion must be primarily solid with ≤ 25% cystic compent\n* No US evidence of extrathyroidal extension through the thyroid capsule\n* No imaging evidence of lymph node metastasis\n* Preserved contralateral vocal cord function prior to PLA\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Thyroid cancer that is non papillary thyroid cancer (PTC)\n* Thyroid lesion with > 25% cystic component\n* Lesion with US evidence of extrathyroidal extension through the thyroid capsule\n* Clinical or ultrasonographic evidence of lymph node metastasis\n* Pregnancy",
    "miscellaneous_criteria": ""
}